Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy J Johnson

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Blood|July 22, 2017
Might broader be better?Amy J Johnson
Blood|July 4, 2009
Mighty mouseAmy J Johnson
Blood|June 13, 2015
Targeted therapies in CLL: mechanisms of resistance and strategies for managementJennifer A Woyach, Amy J Johnson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2012
Molecular pathways: targeting phosphoinositide 3-kinase p110-delta in chronic lymphocytic leukemiaSarah E M Herman, Amy J Johnson
Health Communication|August 15, 2012
Bilingual health communication: distinctive needs of providers from five specialtiesElaine Hsieh, Dyah Pitaloka, Amy J Johnson
Autophagy|February 21, 2013
Autophagy and ER stress play an essential role in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridolEmilia Mahoney, John C Byrd, Amy J Johnson
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Translating PI3K-Delta Inhibitors to the Clinic in Chronic Lymphocytic Leukemia: The Story of CAL-101 (GS1101)John C Byrd, Jennifer A Woyach, Amy J Johnson
Blood|June 21, 2012
The B-cell receptor signaling pathway as a therapeutic target in CLLJennifer A Woyach, Amy J Johnson, John C Byrd
Seminars in Oncology|April 5, 2016
Chronic lymphocytic leukemia: recent progress and current challengesJennifer A Woyach, Amy J Johnson, John C Byrd
Pediatric Cardiology|March 18, 2019
The Significance of Left Axis Deviation in the Pediatric Population: A Meta-AnalysisFu-Sheng Chou, Amy J Johnson, Laxmi V Ghimire
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Blood|July 22, 2017
Might broader be better?Amy J Johnson
Blood|July 4, 2009
Mighty mouseAmy J Johnson
Blood|June 13, 2015
Targeted therapies in CLL: mechanisms of resistance and strategies for managementJennifer A Woyach, Amy J Johnson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2012
Molecular pathways: targeting phosphoinositide 3-kinase p110-delta in chronic lymphocytic leukemiaSarah E M Herman, Amy J Johnson
Health Communication|August 15, 2012
Bilingual health communication: distinctive needs of providers from five specialtiesElaine Hsieh, Dyah Pitaloka, Amy J Johnson
Autophagy|February 21, 2013
Autophagy and ER stress play an essential role in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridolEmilia Mahoney, John C Byrd, Amy J Johnson
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Translating PI3K-Delta Inhibitors to the Clinic in Chronic Lymphocytic Leukemia: The Story of CAL-101 (GS1101)John C Byrd, Jennifer A Woyach, Amy J Johnson
Blood|June 21, 2012
The B-cell receptor signaling pathway as a therapeutic target in CLLJennifer A Woyach, Amy J Johnson, John C Byrd
Seminars in Oncology|April 5, 2016
Chronic lymphocytic leukemia: recent progress and current challengesJennifer A Woyach, Amy J Johnson, John C Byrd
Pediatric Cardiology|March 18, 2019
The Significance of Left Axis Deviation in the Pediatric Population: A Meta-AnalysisFu-Sheng Chou, Amy J Johnson, Laxmi V Ghimire
Pageof 13